Cashman Christopher Michael 4
4 · MARINUS PHARMACEUTICALS INC · Filed Mar 20, 2019
Insider Transaction Report
Form 4
Cashman Christopher Michael
DirectorPresident and CEO
Transactions
- Exercise/Conversion
Stock option (right to buy)
2019-03-18−31,662→ 0 totalExercise: $1.04Exp: 2023-04-04→ Common stock (31,662 underlying) - Exercise/Conversion
Common stock
2019-03-18$1.04/sh+31,662$32,928→ 271,423 total
Footnotes (1)
- [F1]17,596 shares vested on 04/04/2013; remaining shares vested in 43 equal monthly installments